Private label softgel manufacturing in Europe plays an important role in the supplement market, particularly for oil-based formulations and fat-soluble nutrients. In private label projects, softgels are often chosen for their high bioavailability, smooth consumer experience, and ability to protect sensitive ingredients.
Compared to tablets or powders, softgel manufacturing involves a different technological process and requires specialized production environments. Formulation compatibility, capsule shell integrity, and stability considerations all influence the feasibility of a softgel product.
In the European Union, softgel supplements are regulated as food supplements. This means formulation design, packaging decisions, and quality systems must be aligned early to ensure regulatory compliance and stable product performance throughout the product lifecycle.
This article explains how private label softgel supplement projects typically evolve—from concept to manufacturing—and what brands should consider before selecting this dosage form.
In practice, private label softgel manufacturing requires careful alignment between formulation chemistry, capsule shell properties, and packaging protection. Stability, oxidation control, and shell compatibility are critical factors that influence the long-term performance of softgel products.
Softgel supplements are particularly suitable for oil-based nutrients and formulations that benefit from encapsulation in a sealed gelatin shell.
However, successful softgel projects depend on several technical factors, including formulation compatibility, capsule shell stability, and packaging conditions. Brands that evaluate these aspects early are more likely to achieve stable products and predictable production timelines.
Softgels are often selected for several practical and functional reasons:
Softgels are commonly used for products such as:
For many supplement brands, softgels offer a premium presentation while maintaining reliable dosing.
If you are still evaluating dosage forms, see our comparison guide on Capsules vs Tablets vs Softgels vs Powders to understand structural differences in manufacturing and stability.
Softgels are particularly suitable when:
Softgels may not be the best choice when:
Understanding these limitations early helps prevent reformulation later in the project.
Softgel manufacturing differs significantly from capsule filling or tablet compression.
Key technical aspects include:
Unlike hard capsules, softgels are produced through a continuous encapsulation process where the liquid formulation is sealed inside a gelatin shell.
Because the shell and formulation interact chemically over time, formulation compatibility must be evaluated carefully before production begins.
Several challenges can arise in softgel projects if technical feasibility is not assessed early:
These risks do not mean softgels are unstable by default, but they require careful formulation and packaging decisions during early development.
Softgel products are typically packaged in:
Important packaging considerations include:
Improper packaging can lead to capsule sticking, deformation, or oxidation of active ingredients.
As food supplements in the EU, softgel products must comply with applicable food safety and manufacturing regulations.
From a manufacturing perspective, this typically includes:
In the EU, food supplements must comply with general food law requirements defined under Regulation (EC) No 178/2002.
Softgel manufacturing also requires strict environmental controls to ensure consistent capsule shell quality and long-term product stability.
Preparing key information early helps manufacturers evaluate feasibility and provide realistic timelines.
Providing this information early helps avoid delays and supports faster project evaluation.
Softgel supplements are often positioned as premium products within private label portfolios.
At PharmaEurope, softgel feasibility is evaluated based on:
This structured evaluation ensures that softgel products meet both technical and regulatory expectations before manufacturing begins.
Softgel capsules provide an effective delivery format for oil-based nutrients and premium supplement formulations. Their sealed capsule structure protects sensitive ingredients while offering a convenient consumer experience.
However, successful softgel products require careful planning around formulation compatibility, stability, and packaging conditions.
Brands that align these factors early with their manufacturing partner significantly improve product stability and production predictability. Successful private label softgel manufacturing depends on early alignment between formulation, packaging, and stability considerations.
If you are planning a softgel supplement for the European market, our team can help evaluate formulation feasibility, packaging options, and regulatory considerations early in the development process.
Contact our team to discuss your private label supplement project.
If you are considering private label softgel supplements for the EU market, early discussion of formulation feasibility, packaging strategy, and quality requirements can help ensure a smooth development process. Private label softgel manufacturing requires early alignment between formulation design, packaging strategy, and stability planning.
© 2026 PharmaEurope.